Myriad Genetics's total assets for Q2 2025 were $677.30M, a decrease of -32.68% from the previous quarter. MYGN total liabilities were $289.20M for the fiscal quarter, a -3.98% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.